Nucleosides and nucleotides. 150. Enzymatic synthesis of 5′-phosphatidyl derivatives of 1-(2-C-cyano-2-deoxy-β-d-arabino-pentofuranosyl)cytosine (CNDAC (cas 135598-68-4)) and their notable antitumor effects in mice1
-
Add time:08/18/2019 Source:sciencedirect.com
1-(2-C-Cyano-2-deoxy-β-d-arabino-pentofuranosyl)cytosine (CNDAC, 1) is a potent antitumor nucleoside developed by us. A series of 5′-phosphatidyl derivatives of CNDAC bearing various fatty acyl residues, namely dimyristoyl derivative 3a, dipalmitoyl derivative 3b, distearoyl 3c, dioleoyl derivative 3d, and dilinoleoyl derivative 3e, was synthesized by phospholipase D-catalyzed transphosphatidylation. All of these 5′-phosphatidyl-CNDACs (3a-e) administered ip almost perfectly inhibited the growth of sc-implanted M5076 sarcoma in mice, and the effects were clearly superior to that of CNDAC.
We also recommend Trading Suppliers and Manufacturers of CNDAC (cas 135598-68-4). Pls Click Website Link as below: cas 135598-68-4 suppliers
Prev:Antitumor activity of a novel nucleoside, 2′-C-cyano-2′-deoxy-1-β-d-arabinofuranosylcytosine (CNDAC (cas 135598-68-4)) against murine and human tumors
Next:Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Antitumor activity of a novel nucleoside, 2′-C-cyano-2′-deoxy-1-β-d-arabinofuranosylcytosine (CNDAC (cas 135598-68-4)) against murine and human tumors08/17/2019
- Development and biochemical characterization of a 2′-C-cyano-2′-deoxy-1-β-d-arabino-pentofuranosylcytosine (CNDAC (cas 135598-68-4))-resistant variant of the human fibrosarcoma cell line HT-108008/16/2019
- Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2′-C-cyano-2′-deoxy-1-β-d-arabino-pentofuranosylcytosine (CNDAC (cas 135598-68-4))108/15/2019
- Anti-neovascular therapy by liposomal DPP-CNDAC (cas 135598-68-4) targeted to angiogenic vessels08/14/2019


